Global: Early-stage funding in diagnostics, outpatient care and mental health

After the funding frenzy at the start of the year, it was much quieter in early-stage healthcare funding last week. Shanghai-based genomics and molecular diagnostics company NuProbe raised an oversubscribed US$42m round of Series B funding led by BioTrack Capital and Yonghua Capital. Taifu Capital, Panlin Capital, Juming Capital, and Tuobang Capital also participated in…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »